DASA (DASA3) Main Indicators
Basic Data - DASA3
| Company | DASA |
| Corporate Name | DIAGNOSTICOS DA AMERICA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Medicina Diagnóstica. Hospitais e Oncologia. |
| Share | DASA3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 1.86 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 1.17 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Saúde |
| Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
| Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
| Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ISE, ITAG, SMLL |
| Updated 04/02/2025 | |
Relative Prices - DASA3
| Price/Earnings | -1.94 |
| Price/SBV | 0.29 |
| Price/Net Sales | 0.15 |
| Price/CFO | 83.53 |
| Price/FCF | -5.79 |
| Price/Total Assets | 0.09 |
| Price/EBIT | 2.13 |
| Price/Working Capital | 0.80 |
| Price/NCAV | -0.15 |
| EV/EBIT | 10.04 |
| EV/EBITDA | 4.47 |
| EV/Net Sales | 0.72 |
| EV/CFO | 393.21 |
| EV/FCF | -27.28 |
| EV/Total Assets | 0.42 |
| Company Market Cap | R$ 2.33 B |
| Enterprise Value | R$ 10.99 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 1.86 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 0.00% |
| Updated 04/02/2025 | |
Income Statement - DASA3
| Net Revenue | R$ 15.32 B |
| Gross Result | R$ 4.19 B |
| EBIT | R$ 1.09 B |
| Depreciation and Amortization | - R$ 1.37 B |
| EBITDA | R$ 2.46 B |
| Net Profit | - R$ 1.20 B |
| Net Profit/Share | - R$ 0.96 |
| Updated 03/26/2025 | |
| Net Revenue | R$ 3.67 B |
| Gross Result | R$ 846.13 M |
| EBIT | R$ 3.82 M |
| Depreciation and Amortization | - R$ 398.92 M |
| EBITDA | R$ 402.74 M |
| Net Profit | - R$ 832.90 M |
| Profit/Share | - R$ 0.66 |
| Updated 03/26/2025 | |
Price and Volume Behavior - DASA3
| Lowest Price 52 weeks | R$ 1.63 |
| Highest Price 52 weeks | R$ 5.92 |
| Variation 2025 | -0.53% |
| Variation 1 year | -68.58% |
| Variation 2 years(total) | -75.10% |
| Variation 2 years(yearly) | -50.01% |
| Variation 3 years(total) | -91.89% |
| Variation 3 years(yearly) | -56.68% |
| Variation 4 years(total) | -98.68% |
| Variation 4 years(yearly) | -66.09% |
| Variation 5 years(total) | -97.47% |
| Variation 5 years(yearly) | -52.04% |
| Average Daily Volume (3 months) | R$ 1.56 M |
| Updated 04/02/2025 | |
Returns and Margins - DASA3
| Return on Initial Tangible Capital | 7.39% |
| Return on Initial Invested Capital | 4.40% |
| Pre-Tax Return on Initial Tangible Capital | 11.20% |
| Pre-Tax Return on Initial Invested Capital | 6.67% |
| Return on Initial Shareholder´s Equity | -16.38% |
| Return on Initial Asset | -4.58% |
| Gross Margin | 27.37% |
| Net Margin | -7.84% |
| EBIT Margin | 7.14% |
| EBITDA Margin | 16.06% |
| Initial Asset Turnover | 0.58 |
| Financial Leverage | 3.34 |
| Liabilities/Net Worth | 2.34 |
| Net Debt/EBITDA | 3.52 |
| Updated 03/26/2025 | |
Balance Sheet - DASA3
| Cash and Cash Equivalents | R$ 1.74 B |
| Total Assets | R$ 26.46 B |
| Short-Term Debt | R$ 937.85 M |
| Long-Term Debt | R$ 9.46 B |
| Gross Debt | R$ 10.40 B |
| Net Debt | R$ 8.65 B |
| Shareholder´s Equity | R$ 7.93 B |
| Share Book Value | R$ 6.32 |
| Common Shares | 1,255,006,644 |
| Preferred Shares | 0 |
| Total | 1,255,006,644 |
| Common Shares in Treasury | 5,361,750 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 5,361,750 |
| Common Shares (Except Treasury) | 1,249,644,894 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 1,249,644,894 |
| Updated 03/26/2025 | |
Cash Flow - DASA3
| Operating Cash Flow | R$ 27.95 M |
| Cash Flow from Investments | - R$ 373.59 M |
| Financing Cash Flow | R$ 503.22 M |
| Increase (Reduction) in Cash and Equivalents | R$ 157.57 M |
| Updated 03/26/2025 | |
| Operating Cash Flow | R$ 222.82 M |
| Cash Flow from Investments | - R$ 137.97 M |
| Financing Cash Flow | - R$ 1.04 B |
| Increase (Reduction) in Cash and Equivalents | - R$ 955.08 M |
| Updated 03/26/2025 | |
Experimental - DASA3
| CAPEX 3 months | - R$ 251.71 M |
| Free Cash Flow 3 months | - R$ 28.90 M |
| CAPEX 12 months | - R$ 430.81 M |
| Free Cash Flow 12 months | - R$ 402.87 M |
| Updated 03/26/2025 | |